These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 28856834)
1. Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence. Ferdinand KC; Yadav K; Nasser SA; Clayton-Jeter HD; Lewin J; Cryer DR; Senatore FF J Clin Hypertens (Greenwich); 2017 Oct; 19(10):1015-1024. PubMed ID: 28856834 [TBL] [Abstract][Full Text] [Related]
2. Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study. Poon I; Lal LS; Ford ME; Braun UK Ann Pharmacother; 2009 Feb; 43(2):185-93. PubMed ID: 19193586 [TBL] [Abstract][Full Text] [Related]
3. Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth. Yee LM; Liu LY; Sakowicz A; Bolden JR; Miller ES Am J Obstet Gynecol; 2016 Mar; 214(3):374.e1-6. PubMed ID: 26829989 [TBL] [Abstract][Full Text] [Related]
4. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes. Lafata JE; Karter AJ; O'Connor PJ; Morris H; Schmittdiel JA; Ratliff S; Newton KM; Raebel MA; Pathak RD; Thomas A; Butler MG; Reynolds K; Waitzfelder B; Steiner JF J Gen Intern Med; 2016 Feb; 31(2):188-195. PubMed ID: 26282954 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive Medication Use: Implications for Inequities in Cardiovascular Risk and Opportunities for Intervention. LeBrón AM; Schulz AJ; Mentz G; Gamboa C; Reyes A J Health Care Poor Underserved; 2018; 29(1):192-201. PubMed ID: 29503294 [TBL] [Abstract][Full Text] [Related]
6. Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors. Lee M; Salloum RG J Cancer Surviv; 2016 Jun; 10(3):534-44. PubMed ID: 26620816 [TBL] [Abstract][Full Text] [Related]
7. Impact of Medicare Part D on Racial Disparities in Adherence to Cardiovascular Medications Among the Elderly. Hussein M; Waters TM; Chang CF; Bailey JE; Brown LM; Solomon DK Med Care Res Rev; 2016 Aug; 73(4):410-36. PubMed ID: 26577228 [TBL] [Abstract][Full Text] [Related]
8. Application of the nonlinear Blinder-Oaxaca decomposition to study racial/ethnic disparities in antiobesity medication use in the United States. Mehta HB; Rajan SS; Aparasu RR; Johnson ML Res Social Adm Pharm; 2013; 9(1):13-26. PubMed ID: 22554395 [TBL] [Abstract][Full Text] [Related]
9. Disparities in Viral Suppression and Medication Adherence among Women in the USA, 2011-2016. Geter A; Sutton MY; Armon C; Buchacz K; AIDS Behav; 2019 Nov; 23(11):3015-3023. PubMed ID: 30968277 [TBL] [Abstract][Full Text] [Related]
10. Racial/Ethnic differences in medication uptake and clinical outcomes among hospitalized cardiovascular patients with hypertension and diabetes. Mochari-Greenberger H; Mosca L Am J Hypertens; 2015 Jan; 28(1):106-12. PubMed ID: 24904026 [TBL] [Abstract][Full Text] [Related]
11. Racial and Ethnic Differences in Antihypertensive Medication Use and Blood Pressure Control Among US Adults With Hypertension: The National Health and Nutrition Examination Survey, 2003 to 2012. Gu A; Yue Y; Desai RP; Argulian E Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096206 [TBL] [Abstract][Full Text] [Related]
12. Racial/Ethnic Differences in Cost-Related Nonadherence and Medicare Part D: A Longitudinal Comparison. Bakk L J Health Care Poor Underserved; 2015 Nov; 26(4):1132-48. PubMed ID: 26548668 [TBL] [Abstract][Full Text] [Related]
13. Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy. Biggers A; Shi Y; Charlson J; Smith EC; Smallwood AJ; Nattinger AB; Laud PW; Neuner JM J Clin Oncol; 2016 Dec; 34(36):4398-4404. PubMed ID: 27998232 [TBL] [Abstract][Full Text] [Related]
14. Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer. Farias AJ; Du XL J Clin Oncol; 2017 Jan; 35(1):86-95. PubMed ID: 28034069 [TBL] [Abstract][Full Text] [Related]
15. The impact of long-acting medications on attention-deficit/hyperactivity disorder treatment disparities. Saloner B; Fullerton C; McGuire T J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):401-9. PubMed ID: 23952187 [TBL] [Abstract][Full Text] [Related]
16. Racial/Ethnic disparities in the awareness, treatment, and control of hypertension - United States, 2003-2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2013 May; 62(18):351-5. PubMed ID: 23657109 [TBL] [Abstract][Full Text] [Related]
17. Understanding racial disparities in treatment intensification for hypertension management. Manze M; Rose AJ; Orner MB; Berlowitz DR; Kressin NR J Gen Intern Med; 2010 Aug; 25(8):819-25. PubMed ID: 20386998 [TBL] [Abstract][Full Text] [Related]
19. Patient and Facility Correlates of Racial Differences in Viral Control for Black and White Veterans with HIV Infection in the Veterans Administration. Vaughan Sarrazin MS; Ohl ME; Richardson KK; Asch SM; Gifford AL; Bokhour BG AIDS Patient Care STDS; 2018 Mar; 32(3):84-91. PubMed ID: 29620926 [TBL] [Abstract][Full Text] [Related]
20. A Comparison of the Use of Clinical-Guideline-Recommended Antihypertensive Regimens in Mexican American, Non-Hispanic Black, and Non-Hispanic White Adults With Type 2 Diabetes and Hypertension in the United States: NHANES 2003-2012. Perez A; Levin A; Alam N Diabetes Educ; 2016 Dec; 42(6):739-747. PubMed ID: 27621092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]